X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs SUVEN LIFE - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. SUVEN LIFE WOCKHARDT LTD./
SUVEN LIFE
 
P/E (TTM) x -11.3 14.0 - View Chart
P/BV x 2.3 3.3 67.5% View Chart
Dividend Yield % 1.5 0.5 279.1%  

Financials

 WOCKHARDT LTD.   SUVEN LIFE
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
SUVEN LIFE
Mar-17
WOCKHARDT LTD./
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs1,129229 494.1%   
Low Rs627151 415.0%   
Sales per share (Unadj.) Rs363.142.7 850.4%  
Earnings per share (Unadj.) Rs-20.46.9 -298.5%  
Cash flow per share (Unadj.) Rs-7.08.5 -81.8%  
Dividends per share (Unadj.) Rs10.001.00 1,000.0%  
Dividend yield (eoy) %1.10.5 216.2%  
Book value per share (Unadj.) Rs301.852.4 576.0%  
Shares outstanding (eoy) m110.55127.28 86.9%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.44.4 54.4%   
Avg P/E ratio x-42.927.7 -155.0%  
P/CF ratio (eoy) x-125.922.2 -565.9%  
Price / Book Value ratio x2.93.6 80.3%  
Dividend payout %-48.914.6 -335.0%   
Avg Mkt Cap Rs m97,06324,158 401.8%   
No. of employees `0006.81.0 666.1%   
Total wages/salary Rs m9,665522 1,852.6%   
Avg. sales/employee Rs Th5,931.85,349.7 110.9%   
Avg. wages/employee Rs Th1,428.1513.5 278.1%   
Avg. net profit/employee Rs Th-334.0858.1 -38.9%   
INCOME DATA
Net Sales Rs m40,1465,435 738.6%  
Other income Rs m1,143211 541.6%   
Total revenues Rs m41,2895,646 731.3%   
Gross profit Rs m1281,291 9.9%  
Depreciation Rs m1,489214 695.6%   
Interest Rs m2,25357 3,966.0%   
Profit before tax Rs m-2,4721,231 -200.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-211359 -58.8%   
Profit after tax Rs m-2,260872 -259.3%  
Gross profit margin %0.323.7 1.3%  
Effective tax rate %8.529.2 29.3%   
Net profit margin %-5.616.0 -35.1%  
BALANCE SHEET DATA
Current assets Rs m46,1604,917 938.8%   
Current liabilities Rs m19,2581,186 1,623.7%   
Net working cap to sales %67.068.6 97.6%  
Current ratio x2.44.1 57.8%  
Inventory Days Days10162 162.1%  
Debtors Days Days9431 305.6%  
Net fixed assets Rs m40,1653,154 1,273.3%   
Share capital Rs m553127 434.2%   
"Free" reserves Rs m32,8146,543 501.5%   
Net worth Rs m33,3676,670 500.3%   
Long term debt Rs m31,903259 12,303.4%   
Total assets Rs m89,6878,157 1,099.5%  
Interest coverage x-0.122.7 -0.4%   
Debt to equity ratio x1.00 2,459.4%  
Sales to assets ratio x0.40.7 67.2%   
Return on assets %011.4 -0.1%  
Return on equity %-6.813.1 -51.8%  
Return on capital %-0.318.6 -1.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,1214,996 182.6%   
Fx outflow Rs m2,133959 222.4%   
Net fx Rs m6,9884,037 173.1%   
CASH FLOW
From Operations Rs m-2,6951,088 -247.6%  
From Investments Rs m-6,863-3,107 220.9%  
From Financial Activity Rs m12,545-300 -4,178.8%  
Net Cashflow Rs m3,010-2,319 -129.8%  

Share Holding

Indian Promoters % 74.5 63.4 117.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 0.0 -  
FIIs % 7.7 0.0 -  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 36.5 42.2%  
Shareholders   67,757 37,287 181.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   FULFORD INDIA  AUROBINDO PHARMA  IPCA LABS  CADILA HEALTHCARE  SUN PHARMA  

Compare WOCKHARDT LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Up; ONGC & Tata Steel Top Gainers(Closing)

Indian share markets ended the day on a strong note. At the closing bell, the BSE Sensex finished higher by 262 points. While, the NSE Nifty finished up by 91 points.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


May 25, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - DR. DATSONS LABS COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS